共 160 条
[21]
Nonami T(1996)Development of a novel form of an oral 5-fluorouracil derivative (S-1) directed to the potentiation of the tumor selective cytotoxicity of 5-fluorouracil by two biochemical modulators Anticancer Drugs 7 548-557
[22]
Kaneko T(2006)Schedule-dependent therapeutic effects of gemcitabine combined with Uracil-Tegafur in a human pancreatic cancer xenograft model Pancreas 33 142-147
[23]
Takagi H(2006)Phase II trial of oral S-1 combined with gemcitabine in metastatic pancreatic cancer Br J Cancer 94 1575-1579
[24]
Wagner M(2008)Adjuvant gemcitabine plus S-1 chemotherapy after surgical resection for pancreatic adenocarcinoma Am J Surg 195 757-762
[25]
Redaelli C(2006)Intraductal papillary-mucinous neoplasms and mucinous cystic neoplasms of the pancreas differentiated by ovarian-type stroma Surgery 140 448-453
[26]
Lietz M(2007)Predictive factors of malignant or invasive intraductal papillary-mucinous neoplasms of the pancreas J Gastrointest Surg 11 338-344
[27]
Seiler CA(2004)A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer N Engl J Med 350 1200-1210
[28]
Friess H(2007)Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: A randomized controlled trial JAMA 297 267-277
[29]
Büchler MW(2005)Meta-analysis of randomised adjuvant therapy trials for pancreatic cancer Br J Cancer 92 1372-1381
[30]
Magistrelli P(2005)Long-term survival of pancreatic cancer patient diagnosed by positive telomerase activity of pancreatic juice Surgery 138 962-963